Efficacy, Safety, and Tolerability Study of Sotagliflozin as Adjunct Therapy in Adult Patients With Type 1 Diabetes Mellitus Who Have Inadequate Glycemic Control With Insulin Therapy
Clinical trial NCT02421510 · COMPLETED
Trial details
- NCT number
- NCT02421510
- Sponsor
- Lexicon Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-05-01
- Primary completion
- 2016-11-01
- Enrollment
- 782
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.